Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
grade D 0.29 -3.33% -0.01
EARS closed down 3.33 percent on Friday, September 21, 2018, on 27 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical EARS trend table...

Date Alert Name Type % Chg
Sep 21 Fell Below 20 DMA Bearish 0.00%
Sep 21 50 DMA Support Bullish 0.00%
Sep 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Sep 21 Narrow Range Bar Range Contraction 0.00%
Sep 21 Wide Bands Range Expansion 0.00%
Sep 21 Oversold Stochastic Weakness 0.00%
Sep 20 Crossed Above 20 DMA Bullish -3.33%
Sep 20 Crossed Above 50 DMA Bullish -3.33%
Sep 20 Stochastic Buy Signal Bullish -3.33%
Sep 20 Calm After Storm Range Contraction -3.33%

Older signals for EARS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.
Is EARS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.5
52 Week Low 0.23
Average Volume 1,646,463
200-Day Moving Average 1.933
50-Day Moving Average 0.2801
20-Day Moving Average 0.298
10-Day Moving Average 0.3068
Average True Range 0.0431
ADX 27.43
+DI 27.053
-DI 13.6258
Chandelier Exit (Long, 3 ATRs ) 0.3257
Chandelier Exit (Short, 3 ATRs ) 0.3843
Upper Bollinger Band 0.3668
Lower Bollinger Band 0.2292
Percent B (%b) 0.44
BandWidth 46.174497
MACD Line -0.0071
MACD Signal Line -0.0101
MACD Histogram 0.0031
Fundamentals Value
Market Cap 12.86 Million
Num Shares 44.3 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -0.39
Price-to-Sales 0.00
Price-to-Book 6.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.32
Resistance 3 (R3) 0.32 0.31 0.32
Resistance 2 (R2) 0.31 0.30 0.31 0.31
Resistance 1 (R1) 0.30 0.30 0.30 0.30 0.31
Pivot Point 0.29 0.29 0.29 0.29 0.29
Support 1 (S1) 0.28 0.28 0.28 0.28 0.27
Support 2 (S2) 0.27 0.28 0.27 0.27
Support 3 (S3) 0.26 0.27 0.27
Support 4 (S4) 0.26